VALISEEK LIMITED

WC1H 0BS (London)

Start Date End Date Funded Value Relevance

CSV

25 50 100

£215,081

Jan 14 - Dec 15

Tangent Reprofiling. Development of prototype: TAN2004, a safe, known drug formulated for treatment of prostate and lung cancer.

Innovate UK award to VALISEEK LIMITED

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}